Evidence map›Paper›PMID 29695055›Full record

Observational studyNutrients2018

Efficacy of a Moderately Low Carbohydrate Diet in a 36-Month Observational Study of Japanese Patients with Type 2 Diabetes.

Mariko Sanada, Chinatsu Kabe, Hisa Hata, Junichi Uchida, Gaku Inoue, Yoko Tsukamoto, Yoshifumi Yamada, Junichiro Irie, Shogo Tabata, Mitsuhisa Tabata and 1 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Reversal and Remission of T2DM - An Update for Practitioners.Vascular health and risk management · 2022
    Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Mariko SanadaKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. mrksmd@insti.kitasato-u.ac.jp.
Chinatsu KabeKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. kabe@insti.kitasato-u.ac.jp.
Hisa HataKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. h-izumi@insti.kitasato-u.ac.jp.
Junichi UchidaKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. uchida-j@insti.kitasato-u.ac.jp.
Gaku InoueKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. inoueg@pharm.kitasato-u.ac.jp.
Yoko TsukamotoKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. tsuka-y@insti.kitasato-u.ac.jp.
Yoshifumi YamadaBoei Ika Daigakko Boei Igagku Kenkyu Center, 3-2 Namiki, Tokorozawa, Saitama 359-0042, Japan. yamayoshi0718@yahoo.co.jp.
Junichiro IrieSchool of Medicine, Keio University, Internal Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan. j-irie@z8.keio.jp.ORCID 0000-0003-2662-4121
Shogo TabataKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. sky_walker_718@a6.keio.jp.
Mitsuhisa TabataKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. mitsutabata@gmail.com.
Satoru YamadaKitasato Institute Hospital, Diabetes Center, 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan. yamada-s@insti.kitasato-u.ac.jp.
Kitasato Institute Hospital · JPKeio University Hospital · JPNational Defense Medical College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously showed that a non-calorie-restricted, moderately low-carbohydrate diet (mLCD) is more effective than caloric restriction for glycemic and lipid profile control in patients with type 2 diabetes. To determine whether mLCD intervention is sustainable, effective, and safe over a long period, we performed a 36-month observational study. We sequentially enrolled 200 patients with type 2 diabetes and taught them how to follow the mLCD. We compared the following parameters pre- and post-dietary intervention in an outpatient setting: glycated hemoglobin (HbA1c), body weight, lipid profile (total cholesterol, low and high-density lipoprotein cholesterol, triglycerides), systolic and diastolic blood pressure, liver enzymes (aspartate aminotransferase, alanine aminotransferase), and renal function (urea nitrogen, creatinine, estimated glomerular filtration rate). Data from 157 participants were analyzed (43 were lost to follow-up). The following parameters decreased over the period of study: HbA1c (from 8.0 ± 1.5% to 7.5 ± 1.3%,

Indexed as

Diet, Carbohydrate-RestrictedDiet, DiabeticAgedAlanine TransaminaseAspartate AminotransferasesBiomarkersBlood GlucoseBlood Urea NitrogenDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansJapanLipidsMaleMiddle AgedAlanine TransaminaseAspartate AminotransferasesBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanLipidslow-carbohydrate dietobservational studytype 2 diabetes mellitus

Identifiers

PMID29695055
PMCPMC5986408
OpenAlexW2802944954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.